Monthly Archives: April, 2020

April 17,2020: "NHS Digital, the technology services provider for NHS England which runs the service, said it is also planning to provide other datasets...

April 16, 2020: "The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the...

April 16, 2020: "The U.S. Food and Drug Administration announced a further expansion of COVID-19 testing options through the recognition that spun synthetic...

April 15,2020: "Boehringer Ingelheim has significantly stepped up its support to the fight against COVID-19. A Global Support ,Program has been set up to...

April 15, 2020: “The Mount Sinai Health System has partnered with Sana Labs to launch Project Florence, a personalized learning platform to enhance the skills of nurses treating...

April 13, 2020: “A new study from the Icahn School of Medicine at Mount Sinai suggests that blood clots, especially in the lungs, may play a role...

April 15, 2020: “Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company’s proprietary Humaneered® anti-human GM-CSF monoclonal antibody, announced...

April 15, 2020: “Healx, the AI-powered and patient-inspired tech company specialising in accelerating the discovery and development of rare disease treatments, today announced a partnership with...

April 14, 2020: “The first United Nations “Solidarity Flight” is scheduled to leave Addis Ababa, Ethiopia, from there the aircraft will transport the vital...

14 April 2020: “The International Health Regulations Emergency Committee for Ebola in the Democratic Republic of the Congo (DRC) met and has advised me...

April 14, 2020: "Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative...

April 14, 2020: "AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response...